 |
In the first effort of its kind in MS, UCLA neurologist Dr Rhonda Voskuhl is leading a team of investigators at seven US medical centers to conduct a two-year, controlled clinical trial of a sex hormone added to standard therapy to treat MS.
To read more and for contact details, please click on the link below.
Source: US National MS Society
Weblink: click here
|
